Alcobra Ltd (ADHD.O)

ADHD.O on Consolidated Issue listed on NASDAQ Global Market

14.63USD
16 Apr 2014
Price Change (% chg)

$0.60 (+4.28%)
Prev Close
$14.03
Open
$14.14
Day's High
$14.83
Day's Low
$13.85
Volume
76,821
Avg. Vol
114,594
52-wk High
$26.96
52-wk Low
$6.50

ADHD.O

Chart for ADHD.O

About

Alcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and... (more)

Overall

Beta: --
Market Cap (Mil.): $191.32
Shares Outstanding (Mil.): 13.64
Dividend: --
Yield (%): --

Financials

  ADHD.O Industry Sector
P/E (TTM): -- 25.12 32.65
EPS (TTM): -0.93 -- --
ROI: -- -2.94 19.01
ROE: -- -12.86 19.78
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks